FC
CVS icon

Fayerweather Charles’s CVS Health CVS Stock Holding History

Fayerweather Charles’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.18M Buy
18,085
+425
+2% +$26.8K 2.06% 20
2020
Q1 		$1.05M Buy
17,660
+50
+0.3% +$3.34K 2.23% 18
2019
Q4 		$1.31M Sell
17,610
-15
-0.1% -$1.05K 2.17% 18
2019
Q3 		$1.11M Sell
17,625
-4,178
-19% -$248K 1.98% 20
2019
Q2 		$1.19M Sell
21,803
-1,203
-5% -$64.8K 1.79% 23
2019
Q1 		$1.24M Sell
23,006
-130
-0.6% -$8.02K 1.93% 20
2018
Q4 		$1.52M Sell
23,136
-371
-2% -$27.7K 2.71% 16
2018
Q3 		$1.85M Sell
23,507
-3,118
-12% -$223K 2.85% 16
2018
Q2 		$1.71M Sell
26,625
-1,031
-4% -$67.9K 2.74% 16
2018
Q1 		$1.72M Sell
27,656
-970
-3% -$69.6K 2.74% 16
2017
Q4 		$2.08M Sell
28,626
-3,209
-10% -$233K 3.03% 12
2017
Q3 		$2.59M Sell
31,835
-562
-2% -$44.5K 3.39% 10
2017
Q2 		$2.61M Sell
32,397
-1,387
-4% -$110K 3.51% 9
2017
Q1 		$2.65M Sell
33,784
-1,645
-5% -$131K 3.77% 6
2016
Q4 		$2.8M Sell
35,429
-1,275
-3% -$103K 4.17% 5
2016
Q3 		$3.27M Sell
36,704
-741
-2% -$69.9K 4.58% 3
2016
Q2 		$3.59M Sell
37,445
-175
-0.5% -$17.4K 5% 3
2016
Q1 		$3.9M Buy
37,620
+4,405
+13% +$428K 5.5% 1
2015
Q4 		$3.25M Buy
33,215
+16,065
+94% +$1.57M 5.37% 1
2015
Q3 		$1.65M Buy
17,150
+215
+1% +$22.6K 4.5% 3
2015
Q2 		$1.78M Sell
16,935
-600
-3% -$61.3K 4.5% 2
2015
Q1 		$1.81M Buy
17,535
+4,475
+34% +$453K 4.53% 4
2014
Q4 		$1.26M Buy
13,060
+205
+2% +$18.1K 4.27% 6
2014
Q3 		$1.02M Buy
12,855
+30
+0.2% +$2.37K 3.54% 10
2014
Q2 		$967K Sell
12,825
-35
-0.3% -$2.65K 3.3% 10
2014
Q1 		$963K Sell
12,860
-225
-2% -$15.9K 3.34% 10
2013
Q4 		$937K Buy
13,085
+1,425
+12% +$91.6K 3.27% 11
2013
Q3 		$662K Hold
11,660
– – 2.67% 14
2013
Q2 		$667K Buy
+11,660
New +$676K 2.99% 14

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fayerweather Charles's CVS Position: Q2 2020 in Review

Fayerweather Charles increased its CVS Health (CVS) stake by 2.4% in Q2 2020, buying an estimated $26.8K and bringing the position to 18,085 shares worth $1.18M. The position accounts for 2.06% of the portfolio, ranked #20.

Fayerweather Charles first reported a position in CVS in Q2 2013 and has held it in 29 quarters since. The position peaked at $3.9M in Q1 2016. 1,864 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • Fayerweather Charles held 18,085 shares of CVS Health worth $1.18M as of Q2 2020.
  • Fayerweather Charles bought 425 CVS Health shares in Q2 2020, an estimated $26.8K.
  • CVS Health made up 2.06% of Fayerweather Charles's portfolio in Q2 2020, its #20 holding.
  • Fayerweather Charles first reported a position in CVS Health in Q2 2013 and has held it in 29 quarters since.
  • Fayerweather Charles's CVS Health position peaked at $3.9M in Q1 2016.
  • 1,864 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on Fayerweather Charles's 13F filing for Q2 2020, filed 28 Jul 2020.